Product Information
LAMICTAL 25 MG DISPER TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $11.1816 per EA under NDC 00173052700. Its NADAC has been published 619 times since Nov 28, 2013.
FDA first approved this application on Aug 24, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173052700
Classification
Brand
Dosage Form
TABLET, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
New Drug (NDA)
FDA Application
NDA020764FDA Approved
8/24/1998
TE Code
AB
On Market Since
9/3/1998
Pharmacological Classes
Price Statistics
The NADAC for LAMICTAL 25 MG DISPER TABLET has been published 619 times since Nov 28, 2013, and over the history we have for it it has risen 69.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1816 per EA |
|---|---|
| All-time high | $15.7903 (Dec 20, 2023) |
| All-time low | $6.5949 (Nov 28, 2013) |
| 52-week high | $11.2319 |
| 52-week low | $11.1816 |
| Median price | $11.2992 |
| Average price | $11.8325 |
| Largest weekly change | -31.0% (Dec 27, 2023) |
| Weeks tracked | 619 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMICTAL 25 MG DISPER TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL 25 MG DISPER TABLET, manufactured by GlaxoSmithKline LLC, is $11.1816 per EA (NDC 00173052700), effective Aug 19, 2026.
How has the price of LAMICTAL 25 MG DISPER TABLET changed over time?
Over the history we have for it, the NADAC for LAMICTAL 25 MG DISPER TABLET has risen 69.5%. It has been tracked across 619 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMICTAL 25 MG DISPER TABLET?
Since Nov 28, 2013, the NADAC for LAMICTAL 25 MG DISPER TABLET has ranged from a low of $6.5949 (Nov 28, 2013) to a high of $15.7903 (Dec 20, 2023), with a median of $11.2992 per EA.
Are there cheaper alternatives to LAMICTAL 25 MG DISPER TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG DISPER TAB, is $0.1497 per EA — about 99% below LAMICTAL 25 MG DISPER TABLET.
Who manufactures LAMICTAL 25 MG DISPER TABLET?
LAMICTAL 25 MG DISPER TABLET (NDC 00173052700) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.